LAE-106

N/A

Report date: 2023/11/03 10:04:20

Base Information

Drug NameLAE-106
Drug Alias NameLAE-106
ClassificationSmall molecules
Mechanisms of ActionTransforming growth factor beta inhibitors
TargetsTransforming growth factor beta
Therapy Area/IndicationsPulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLaekna Therapeutics Shanghai Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLaekna Therapeutics Shanghai Co Ltd
Inactive CompaniesN/A
Active IndicationsPulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A